Correction to "Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase"

ACS Omega. 2022 Jun 13;7(25):22059-22060. doi: 10.1021/acsomega.2c03469. eCollection 2022 Jun 28.

Luca Mologni^{1

2}, Sébastien Tardy^{3

4

5}, Alfonso Zambon⁶, Alexandre Orsato^{3

7}, Cédric Schneider^{3

8}, William H Bisson^{4

9}, Monica Ceccon¹, Michela Viltadi¹, David Goyard^{3

10}, Pierre Garcia³, Joseph D'Attoma³, Sara Pannilunghi^{4

5}, Vito Vece^{1

11}, Jerome Bertho², David Gueyrard³, Peter Goekjian^{2

3}, Leonardo Scapozza^{2

4

5}, Carlo Gambacorti-Passerini^{1

2}

¹ Department of Medicine and Surgery, University of Milano-Bicocca, Monza 20900, Italy.
² Galkem srl, Monza 20900, Italy.
³ Laboratoire Chimie Organique 2-Glycochimie, CNRS-Université Claude Bernard Lyon 1, Villeurbanne 69100, France.
⁴ School of Pharmaceutical Sciences, University of Geneva, Geneva 1211, Switzerland.
⁵ Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva 1211, Switzerland.
⁶ Department of Chemistry and Geological Sciences, University of Modena and Reggio Emilia, Modena 41125, Italy.
⁷ Department of Chemistry, Universidade Estadual de Londrina, Paraná 86057-970, Brazil.
⁸ Université de Rouen, Mont-Saint-Aignan 76000, France.
⁹ Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97227, United States.
¹⁰ Université Grenoble Alpes, Grenoble 38000, France.
¹¹ Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.

Abstract

[This corrects the article DOI: 10.1021/acsomega.2c00507.].